-
Signature
-
/s/ Ilya Rachman as Attorney-In-Fact for Magda Marquet
-
Issuer symbol
-
IMMX
-
Transactions as of
-
20 Jun 2025
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
23 Jun 2025, 16:57:36 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Marquet Magda |
Director |
C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES |
/s/ Ilya Rachman as Attorney-In-Fact for Magda Marquet |
23 Jun 2025 |
0001631486 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| holding |
IMMX |
Common Stock |
|
|
|
|
|
46,092 |
20 Jun 2025 |
Direct |
|
| holding |
IMMX |
Common Stock |
|
|
|
|
|
20,000 |
20 Jun 2025 |
Via ALMA Life Sciences, LLC |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IMMX |
Stock Option (Right to Buy) |
Award |
$0 |
+33,000 |
|
$0.000000 |
33,000 |
20 Jun 2025 |
Common Stock |
33,000 |
$2.24 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
See Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the Reporting Person on December 15, 2021.